BLUM ROBERT I (President & CEO) sold 7.8% of their position (36.60K shares) of CYTOKINETICS INC on the open market
Open‑market sale worth $2.27M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/18/2026ACC: 0001061983-26-000026
DirectorOfficer· President & CEO
Since Jul 2018
-36.60K
Net shares
Net seller
$2.27M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
36.60K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−12.67K
Price / share
$62.15
Trade value
$787.63K
% of position
2.7%
3/17/2026
466.93K→454.26K
Common Stock
Direct
Shares
−23.93K
Price / share
$62.15
Trade value
$1.49M
% of position
5.3%
3/17/2026
454.26K→430.33K
Total
Net shares
−36.60K
Net value
-$2.27M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/17/2026 | S · Sale | −12.67K | $62.15 | $787.63K | 2.7% | 466.93K | 454.26K |
| Common Stock Direct | 3/17/2026 | S · Sale | −23.93K | $62.15 | $1.49M | 5.3% | 454.26K | 430.33K |
| Total | −36.60K | -$2.27M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned2.08K
Common Stock
IndirectShares owned2.08K
Total
4.17K indirect4.17K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2.08K | Indirect |
| Common Stock | 2.08K | Indirect |
| Total | 4.17K | 4.17K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported